Sercan Aksoy

Also affiliated with Ankara Onkoloji Eğitim ve Araştırma Hastanesi, Hacettepe University Hospital, Burdur Mehmet Akif Ersoy Üniversitesi, Hacettepe University

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer”.

Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer

Cancer Research(2024)10.1158/0008-5472.can-23-2812

N/A

1.1DataRank · unranked

28 citations

Özge Saatci, Nathaniel Oberholtzer, Meral Üner, Özge Akbulut, Metin Çetįn +10 more

Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer

Nature Communications(2020)10.1038/s41467-020-16199-4

N/A

0.888DataRank · unranked

371 citations

Aysegül Kaymak, Umar Raza, Pelin G. Ersan, Özge Akbulut, Carolyn E. Banister +18 more

Targeting LINC00152 activates cAMP/Ca2+/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer

Cell Death and Disease(2024)10.1038/s41419-024-06814-3

N/A

0.804DataRank · unranked

31 citations

Rashedul Alam, Kim‐Tuyen Huynh‐Dam, Aynur Işık, Meral Üner, Nevin Belder +17 more

Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer

Nature Communications(2023)10.1038/s41467-023-42736-y

N/A

0.396DataRank · unranked

13 citations

Metin Çetįn, Meral Üner, Ünal Metin Tokat, Ioulia Chatzistamou, Pelin G. Ersan +8 more

Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification

Cell Death and Differentiation(2023)10.1038/s41418-023-01140-1

N/A

0DataRank · unranked

35 citations

Özge Akbulut, Metin Çetįn, Vitali Sikirzhytski, Meral Üner, Deniz Lengerli +8 more

Targeting LINC00152 activates cAMP/Ca 2+ /ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.11.05.565697

N/A

0DataRank · unranked

2 citations

R. T. M. Alam, Kim‐Tuyen Huynh‐Dam, Aynur Işık, Meral Üner, Nevin Belder +15 more